Zhenjiang, China

Jun Liu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Liu. Retrieved from https://idiyas.com/inventor/jun-liu-hbtplsh9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun Liu - Innovator in Pharmaceutical Chemistry

Introduction

Jun Liu is a notable inventor based in Zhenjiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have therapeutic applications.

Latest Patents

Jun Liu holds a patent for a 2-aryl selenazole compound and its pharmaceutical composition. This compound is represented by a specific formula and is recognized for its ability to inhibit xanthine oxidase. The 2-aryl selenazole compound can be utilized in the development of drugs aimed at preventing or treating conditions such as hyperuricemia, gout, diabetic nephropathy, inflammatory diseases, and neurological disorders. He has 1 patent to his name.

Career Highlights

Throughout his career, Jun Liu has worked with Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. and Atom Bioscience and Pharmaceutical Co. Ltd. These experiences have allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical science.

Collaborations

Jun Liu has collaborated with notable colleagues, including Dongfang Shi and Changjin Fu. Their combined expertise has likely enhanced the research and development efforts in their respective projects.

Conclusion

Jun Liu's work in developing pharmaceutical compounds showcases his innovative spirit and dedication to improving healthcare solutions. His contributions are valuable to the field of pharmaceutical chemistry and have the potential to impact many lives positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…